362 related articles for article (PubMed ID: 37698911)
1. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.
Huang G; Jin Q; Mao Y
J Med Internet Res; 2023 Sep; 25():e46891. PubMed ID: 37698911
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of machine learning models for nonalcoholic fatty liver disease.
Peng HY; Duan SJ; Pan L; Wang MY; Chen JL; Wang YC; Yao SK
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):615-621. PubMed ID: 37005147
[TBL] [Abstract][Full Text] [Related]
3. Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study.
Liu YX; Liu X; Cen C; Li X; Liu JM; Ming ZY; Yu SF; Tang XF; Zhou L; Yu J; Huang KJ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):409-415. PubMed ID: 34420885
[TBL] [Abstract][Full Text] [Related]
4. Predicting the risk of subclinical atherosclerosis based on interpretable machine models in a Chinese T2DM population.
Tusongtuoheti X; Shu Y; Huang G; Mao Y
Front Endocrinol (Lausanne); 2024; 15():1332982. PubMed ID: 38476673
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial Use of Machine Learning and Logistic Regression for Predicting Carotid Plaque Risk Among 5.4 Million Adults With Fatty Liver Disease Receiving Health Check-Ups: Population-Based Cross-Sectional Study.
Deng Y; Ma Y; Fu J; Wang X; Yu C; Lv J; Man S; Wang B; Li L
JMIR Public Health Surveill; 2023 Sep; 9():e47095. PubMed ID: 37676713
[TBL] [Abstract][Full Text] [Related]
6. A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.
Cai X; Zhu Q; Cao Y; Liu S; Wang M; Wu T; Hong J; Ahmat A; Aierken X; Li N
Biomed Res Int; 2021; 2021():5527460. PubMed ID: 34095297
[TBL] [Abstract][Full Text] [Related]
7. Machine learning classifiers for screening nonalcoholic fatty liver disease in general adults.
Qin S; Hou X; Wen Y; Wang C; Tan X; Tian H; Ao Q; Li J; Chu S
Sci Rep; 2023 Mar; 13(1):3638. PubMed ID: 36869105
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.
Pan H; Liu B; Luo X; Shen X; Sun J; Zhang A
Lipids Health Dis; 2023 Nov; 22(1):205. PubMed ID: 38007441
[TBL] [Abstract][Full Text] [Related]
9. Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study.
Xiao Y; Chen Y; Huang R; Jiang F; Zhou J; Yang T
BMC Med Res Methodol; 2024 Apr; 24(1):92. PubMed ID: 38643122
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a machine learning predictive model for non-alcoholic fatty liver disease: A longitudinal cohort study.
Cao T; Zhu Q; Tong C; Halengbieke A; Ni X; Tang J; Han Y; Li Q; Yang X
Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1456-1466. PubMed ID: 38508988
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China.
Li D; Zhang M; Wu S; Tan H; Li N
Sci Rep; 2022 Aug; 12(1):13877. PubMed ID: 35974018
[TBL] [Abstract][Full Text] [Related]
12. A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study.
Cai X; Aierken X; Ahmat A; Cao Y; Zhu Q; Wu T; Li N
Biomed Res Int; 2020; 2020():8852198. PubMed ID: 33204721
[TBL] [Abstract][Full Text] [Related]
13. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
15. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
[TBL] [Abstract][Full Text] [Related]
16. A dynamic machine learning model for prediction of NAFLD in a health checkup population: A longitudinal study.
Deng Y; Ma Y; Fu J; Wang X; Yu C; Lv J; Man S; Wang B; Li L
Heliyon; 2023 Aug; 9(8):e18758. PubMed ID: 37576311
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods.
Lee SM; Hwangbo S; Norwitz ER; Koo JN; Oh IH; Choi ES; Jung YM; Kim SM; Kim BJ; Kim SY; Kim GM; Kim W; Joo SK; Shin S; Park CW; Park T; Park JS
Clin Mol Hepatol; 2022 Jan; 28(1):105-116. PubMed ID: 34649307
[TBL] [Abstract][Full Text] [Related]
18. Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy-confirmed NAFLD.
Feng G; Zheng KI; Li YY; Rios RS; Zhu PW; Pan XY; Li G; Ma HL; Tang LJ; Byrne CD; Targher G; He N; Mi M; Chen YP; Zheng MH
J Hepatobiliary Pancreat Sci; 2021 Jul; 28(7):593-603. PubMed ID: 33908180
[TBL] [Abstract][Full Text] [Related]
19. Biological signatures and prediction of an immunosuppressive status-persistent critical illness-among orthopedic trauma patients using machine learning techniques.
Lei M; Han Z; Wang S; Guo C; Zhang X; Song Y; Lin F; Huang T
Front Immunol; 2022; 13():979877. PubMed ID: 36325351
[TBL] [Abstract][Full Text] [Related]
20. Machine Learning-Based Prediction of Acute Kidney Injury Following Pediatric Cardiac Surgery: Model Development and Validation Study.
Luo XQ; Kang YX; Duan SB; Yan P; Song GB; Zhang NY; Yang SK; Li JX; Zhang H
J Med Internet Res; 2023 Jan; 25():e41142. PubMed ID: 36603200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
